Sign In
Buy BVNKF
$27.69
+0 (+0%)
At Close: Jul 31, 2026
Bavarian Nordic Announces Major Shareholder Notification from Morgan Stanley
03:00pm, Monday, 10'th Nov 2025
COPENHAGEN, Denmark, November 10, 2025 – Pursuant to section 30 of the Danish Capital Markets Act, Bavarian Nordic A/S hereby announces that the Company has received notification from Morgan Stanley
Bavarian Nordic Announces Major Shareholder Notification from Morgan Stanley
11:30am, Friday, 07'th Nov 2025
COPENHAGEN, Denmark, November 7, 2025 – Pursuant to section 30 of the Danish Capital Markets Act, Bavarian Nordic A/S hereby announces that the Company has received notification from Morgan Stanley
Nordic Capital, Permira takeover offer for Bavarian Nordic falls through
09:29am, Thursday, 06'th Nov 2025
Innosera, a consortium led by Nordic Capital and Permira, failed to achieve the required level of support from shareholders for its planned takeover of Bavarian Nordic and will withdraw its bid, Bavar
Bavarian Nordic Provides Clarification on the HERA Framework Agreement and the Public Preparedness Business
05:34am, Saturday, 01'st Nov 2025
COPENHAGEN, Denmark, November 1, 2025 – Bavarian Nordic A/S hereby issues the following clarification regarding the Health Emergency Preparedness and Response Authority (HERA) framework agreement, a
Bavarian Nordic Announces Major Shareholder Notification from Morgan Stanley
10:56am, Friday, 31'st Oct 2025
COPENHAGEN, Denmark, October 31, 2025 – Pursuant to section 30 of the Danish Capital Markets Act, Bavarian Nordic A/S hereby announces that the Company has received notification from Morgan Stanley
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION
Bavarian Nordic signs EU smallpox and mpox vaccine contract for up to 8 million doses
05:55am, Friday, 31'st Oct 2025
Bavarian Nordic announced on Friday a new contract with the European Commission, allowing countries across Europe to buy up to eight million doses of its smallpox and mpox vaccine over the next four y
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION
Bavarian Nordic's Largest Shareholder Stands Firm Against $3.1 Billion Private-Equity Takeover Bid
09:44am, Thursday, 16'th Oct 2025
ATP's rejection of a sweetened bid from private-equity firms for the vaccine maker casts doubt over whether the deal will go through.
Nordic Capital-led consortium raises takeover price for Bavarian Nordic to $38.94 per share
01:22pm, Wednesday, 15'th Oct 2025
Bavarian Nordic said on Wednesday a consortium led by Nordic Capital and Permira has raised its offer price for the vaccine maker to 250 Danish crowns ($38.94) after its initial bid was not accepted b
Bavarian Nordic A/S (BVNKF) Q2 2025 Earnings Call Transcript
01:36pm, Friday, 22'nd Aug 2025
Bavarian Nordic A/S (OTCPK:BVNKF) Q2 2025 Earnings Conference Call August 22, 2025 8:00 AM ET Company Participants Henrik Juuel - CFO & Executive VP Paul John Chaplin - CEO & President Rolf Sass Soren
Bavarian Nordic beats revenue expectations, as launch of takeover bid nears
05:44am, Friday, 22'nd Aug 2025
Bavarian Nordic , subject of a takeover offer valuing the vaccine maker at about 19 billion Danish crowns ($3 billion), reported a higher than expected revenue for the second quarter on Friday, citing
Consortium led by Nordic Capital, Permira to acquire Bavarian Nordic
02:33am, Monday, 28'th Jul 2025
Vaccine maker Bavarian Nordic said on Monday it had entered into an agreement with Innosera ApS, a newly formed company controlled by a consortium led by Nordic Capital and Permira, which is to make a
Bavarian Nordic in talks with Nordic Capital and Permira on potential takeover
10:12am, Thursday, 24'th Jul 2025
Danish biotech Bavarian Nordic said on Thursday it is in discussions with a consortium of Nordic Capital and Permira regarding a potential takeover offer.
Bavarian Nordic Enters New Smallpox/Mpox Vaccine Supply Contract with European Country
10:46am, Wednesday, 09'th Jul 2025
COPENHAGEN, Denmark, July 9, 2025 – Bavarian Nordic A/S (OMX: BAVA) today announced the award of a contract valued over DKK 200 million to supply its MVA-BN® smallpox/mpox vaccine to a European cou
